Vaccine provides protection against particular diseases by improving immunity. Vaccines are the biological preparations of weakened or killed microorganism, its surface proteins or its toxins.
Scope of the Report:
The global paediatric vaccine market is expected to grow at a healthy CAGR in next few years.
Increase in growth would be primarily attributed to improved understanding of immunology, which has resulted in launch of new vaccines products. Technological breakthrough has led to development of new vaccine class such as DNA vaccines, vector vaccines, intranasal vaccines, mucosal vaccines and others.
However, manufacturing complexity and stringent regulatory compliance are the factors that hinder the market growth. Refusal to immunization and vaccines shortages are other restraints for this market.
The worldwide market for Paediatric Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Paediatric Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
GlaxoSmithCline
Merck
Sanofi
Bristol-Myers Squibb
Abbott Laboratories
Eli Lilly
Pfizer
F. Hoffmann-La Roche
Novo Nordisk
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pneumococcal
Varicella
Combinations
Poliovirus
Hepatitis
MMR
Pediatric Hormones
HIB
Allergy and Respiratory vaccines
Other Pediatric vaccines
Market Segment by Applications, can be divided into
Age (0-3)
Age (3-12)
Age Above 12
There are 15 Chapters to deeply display the global Paediatric Vaccine market.
Chapter 1, to describe Paediatric Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Paediatric Vaccine, with sales, revenue, and price of Paediatric Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Paediatric Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Paediatric Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Paediatric Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Paediatric Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Pneumococcal
1.2.2 Varicella
1.2.3 Combinations
1.2.4 Poliovirus
1.2.5 Hepatitis
1.2.6 MMR
1.2.7 Pediatric Hormones
1.2.8 HIB
1.2.9 Allergy and Respiratory vaccines
1.2.10 Other Pediatric vaccines
1.3 Market Analysis by Applications
1.3.1 Age (0-3)
1.3.2 Age (3-12)
1.3.3 Age Above 12
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithCline
2.1.1 Business Overview
2.1.2 Paediatric Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithCline Paediatric Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Paediatric Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Paediatric Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Paediatric Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Paediatric Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bristol-Myers Squibb
2.4.1 Business Overview
2.4.2 Paediatric Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Paediatric Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Abbott Laboratories
2.5.1 Business Overview
2.5.2 Paediatric Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Laboratories Paediatric Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Paediatric Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly Paediatric Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Paediatric Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Paediatric Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 F. Hoffmann-La Roche
2.8.1 Business Overview
2.8.2 Paediatric Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 F. Hoffmann-La Roche Paediatric Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novo Nordisk
2.9.1 Business Overview
2.9.2 Paediatric Vaccine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novo Nordisk Paediatric Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Paediatric Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Paediatric Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Paediatric Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Paediatric Vaccine Manufacturer Market Share in 2017
3.3.2 Top 6 Paediatric Vaccine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Paediatric Vaccine Market Analysis by Regions
4.1 Global Paediatric Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Paediatric Vaccine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Paediatric Vaccine Revenue and Market Share by Regions (2013-2018)
4.2 North America Paediatric Vaccine Sales and Growth Rate (2013-2018)
4.3 Europe Paediatric Vaccine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Paediatric Vaccine Sales and Growth Rate (2013-2018)
4.5 South America Paediatric Vaccine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Paediatric Vaccine Sales and Growth Rate (2013-2018)
5 North America Paediatric Vaccine by Countries
5.1 North America Paediatric Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Paediatric Vaccine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Paediatric Vaccine Revenue and Market Share by Countries (2013-2018)
5.2 United States Paediatric Vaccine Sales and Growth Rate (2013-2018)
5.3 Canada Paediatric Vaccine Sales and Growth Rate (2013-2018)
5.4 Mexico Paediatric Vaccine Sales and Growth Rate (2013-2018)
6 Europe Paediatric Vaccine by Countries
6.1 Europe Paediatric Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Paediatric Vaccine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Paediatric Vaccine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Paediatric Vaccine Sales and Growth Rate (2013-2018)
6.3 UK Paediatric Vaccine Sales and Growth Rate (2013-2018)
6.4 France Paediatric Vaccine Sales and Growth Rate (2013-2018)
6.5 Russia Paediatric Vaccine Sales and Growth Rate (2013-2018)
6.6 Italy Paediatric Vaccine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Paediatric Vaccine by Countries
7.1 Asia-Pacific Paediatric Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Paediatric Vaccine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Paediatric Vaccine Revenue and Market Share by Countries (2013-2018)
7.2 China Paediatric Vaccine Sales and Growth Rate (2013-2018)
7.3 Japan Paediatric Vaccine Sales and Growth Rate (2013-2018)
7.4 Korea Paediatric Vaccine Sales and Growth Rate (2013-2018)
7.5 India Paediatric Vaccine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Paediatric Vaccine Sales and Growth Rate (2013-2018)
8 South America Paediatric Vaccine by Countries
8.1 South America Paediatric Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Paediatric Vaccine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Paediatric Vaccine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Paediatric Vaccine Sales and Growth Rate (2013-2018)
8.3 Argentina Paediatric Vaccine Sales and Growth Rate (2013-2018)
8.4 Colombia Paediatric Vaccine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Paediatric Vaccine by Countries
9.1 Middle East and Africa Paediatric Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Paediatric Vaccine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Paediatric Vaccine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Paediatric Vaccine Sales and Growth Rate (2013-2018)
9.3 UAE Paediatric Vaccine Sales and Growth Rate (2013-2018)
9.4 Egypt Paediatric Vaccine Sales and Growth Rate (2013-2018)
9.5 Nigeria Paediatric Vaccine Sales and Growth Rate (2013-2018)
9.6 South Africa Paediatric Vaccine Sales and Growth Rate (2013-2018)
10 Global Paediatric Vaccine Market Segment by Type
10.1 Global Paediatric Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Paediatric Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Paediatric Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Pneumococcal Sales Growth and Price
10.2.1 Global Pneumococcal Sales Growth (2013-2018)
10.2.2 Global Pneumococcal Price (2013-2018)
10.3 Varicella Sales Growth and Price
10.3.1 Global Varicella Sales Growth (2013-2018)
10.3.2 Global Varicella Price (2013-2018)
10.4 Combinations Sales Growth and Price
10.4.1 Global Combinations Sales Growth (2013-2018)
10.4.2 Global Combinations Price (2013-2018)
10.5 Poliovirus Sales Growth and Price
10.5.1 Global Poliovirus Sales Growth (2013-2018)
10.5.2 Global Poliovirus Price (2013-2018)
10.6 Hepatitis Sales Growth and Price
10.6.1 Global Hepatitis Sales Growth (2013-2018)
10.6.2 Global Hepatitis Price (2013-2018)
10.7 MMR Sales Growth and Price
10.7.1 Global MMR Sales Growth (2013-2018)
10.7.2 Global MMR Price (2013-2018)
10.8 Pediatric Hormones Sales Growth and Price
10.8.1 Global Pediatric Hormones Sales Growth (2013-2018)
10.8.2 Global Pediatric Hormones Price (2013-2018)
10.9 HIB Sales Growth and Price
10.9.1 Global HIB Sales Growth (2013-2018)
10.9.2 Global HIB Price (2013-2018)
10.10 Allergy and Respiratory vaccines Sales Growth and Price
10.10.1 Global Allergy and Respiratory vaccines Sales Growth (2013-2018)
10.10.2 Global Allergy and Respiratory vaccines Price (2013-2018)
10.11 Other Pediatric vaccines Sales Growth and Price
10.11.1 Global Other Pediatric vaccines Sales Growth (2013-2018)
10.11.2 Global Other Pediatric vaccines Price (2013-2018)
11 Global Paediatric Vaccine Market Segment by Application
11.1 Global Paediatric Vaccine Sales Market Share by Application (2013-2018)
11.2 Age (0-3) Sales Growth (2013-2018)
11.3 Age (3-12) Sales Growth (2013-2018)
11.4 Age Above 12 Sales Growth (2013-2018)
12 Paediatric Vaccine Market Forecast (2018-2023)
12.1 Global Paediatric Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Paediatric Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Paediatric Vaccine Market Forecast (2018-2023)
12.2.2 Europe Paediatric Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Paediatric Vaccine Market Forecast (2018-2023)
12.2.4 South America Paediatric Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Paediatric Vaccine Market Forecast (2018-2023)
12.3 Paediatric Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Paediatric Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Paediatric Vaccine Market Share Forecast by Type (2018-2023)
12.4 Paediatric Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Paediatric Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Paediatric Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Paediatric Vaccine Picture
Table Product Specifications of Paediatric Vaccine
Figure Global Sales Market Share of Paediatric Vaccine by Types in 2017
Ta